Tumor necrosis factor ligand superfamily member 13B
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 6 PDB declaration: hexameric(6) Consistent with protein copy count | Chain A; UniProt 82–285 Chain B; UniProt 82–285 Chain C; UniProt 82–285 | Not recorded | BR3 derived peptive × 3 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed experimental conditions | Resolution 3.00 Å R-free 0.200 |
| 2 | Protein heterocomplex Heteromer Protein × 6 PDB declaration: hexameric(6) Consistent with protein copy count | Chain D; UniProt 82–285 Chain E; UniProt 82–285 Chain F; UniProt 82–285 | Not recorded | BR3 derived peptive × 3 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed experimental conditions | Resolution 3.00 Å R-free 0.200 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 3V56 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1JH5 Crystal Structure of sTALL-1 of TNF family ligand Deposited 2001-06-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 60 PDB declaration: 60-meric |
Chain A
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain B
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain C
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain D
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain E
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain F
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain G
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain H
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain I
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain J
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9;277 K;35% dioxane, pH 9.0, VAPOR DIFFUSION, HANGING DROP at 277K
|
Resolution 3.00 Å R-free 0.252 |
| 1KD7 Crystal structure of an extracellular domain fragment of human BAFF Deposited 2001-11-12 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
122–285(164 aa)
Fragment:Extracellular domain fragment
Chain B
122–285(164 aa)
Fragment:Extracellular domain fragment
Chain C
122–285(164 aa)
Fragment:Extracellular domain fragment
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;8% PEG 4000, 0.1 M sodium acetatesolution of 8% PEG 4000, 0.1 M sodium acetate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å R-free 0.250 |
| 1KD7 Crystal structure of an extracellular domain fragment of human BAFF Deposited 2001-11-12 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain K
122–285(164 aa)
Fragment:Extracellular domain fragment
Chain L
122–285(164 aa)
Fragment:Extracellular domain fragment
Chain M
122–285(164 aa)
Fragment:Extracellular domain fragment
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;8% PEG 4000, 0.1 M sodium acetatesolution of 8% PEG 4000, 0.1 M sodium acetate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å R-free 0.250 |
| 1KXG The 2.0 Ang Resolution Structure of BLyS, B Lymphocyte Stimulator. Deposited 2002-01-31 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
Chain B
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
Chain C
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
|
Not recorded | MG MAGNESIUM ION × 4 CIT CITRIC ACID × 1 DIO 1,4-DIETHYLENE DIOXIDE × 13 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;279 K;25% dioxane, 25 mM MgCl2, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 279.0K
|
Resolution 2.00 Å R-free 0.209 |
| 1KXG The 2.0 Ang Resolution Structure of BLyS, B Lymphocyte Stimulator. Deposited 2002-01-31 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain D
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
Chain E
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
Chain F
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
|
Not recorded | MG MAGNESIUM ION × 3 CIT CITRIC ACID × 1 DIO 1,4-DIETHYLENE DIOXIDE × 7 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;279 K;25% dioxane, 25 mM MgCl2, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 279.0K
|
Resolution 2.00 Å R-free 0.209 |
| 1OQD Crystal structure of sTALL-1 and BCMA Deposited 2003-03-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 108 PDB declaration: 108-meric |
Chain A
142–285(144 aa)
Fragment:extracellular domain
Chain B
142–285(144 aa)
Fragment:extracellular domain
Chain C
142–285(144 aa)
Fragment:extracellular domain
Chain D
142–285(144 aa)
Fragment:extracellular domain
Chain E
142–285(144 aa)
Fragment:extracellular domain
Chain F
142–285(144 aa)
Fragment:extracellular domain
Chain G
142–285(144 aa)
Fragment:extracellular domain
Chain H
142–285(144 aa)
Fragment:extracellular domain
Chain I
142–285(144 aa)
Fragment:extracellular domain
Chain J
142–285(144 aa)
Fragment:extracellular domain
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9;277 K;dioxane, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.60 Å R-free 0.260 |
| 1OQE Crystal structure of sTALL-1 with BAFF-R Deposited 2003-03-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 108 PDB declaration: 108-meric |
Chain A
142–285(144 aa)
Fragment:extracellular domain
Chain B
142–285(144 aa)
Fragment:extracellular domain
Chain C
142–285(144 aa)
Fragment:extracellular domain
Chain D
142–285(144 aa)
Fragment:extracellular domain
Chain E
142–285(144 aa)
Fragment:extracellular domain
Chain F
142–285(144 aa)
Fragment:extracellular domain
Chain G
142–285(144 aa)
Fragment:extracellular domain
Chain H
142–285(144 aa)
Fragment:extracellular domain
Chain I
142–285(144 aa)
Fragment:extracellular domain
Chain J
142–285(144 aa)
Fragment:extracellular domain
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9;dioxane, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 100K
|
Resolution 2.50 Å R-free 0.259 |
| 1OSG Complex between BAFF and a BR3 derived peptide presented in a beta-hairpin scaffold Deposited 2003-03-19 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
82–285(204 aa)
Fragment:TNF domain
Chain B
82–285(204 aa)
Fragment:TNF domain
Chain C
82–285(204 aa)
Fragment:TNF domain
|
Not recorded | MG MAGNESIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;292 K;20% PEG 3350, 1.0 M LiCl, 0.1M sodium cacodylate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 3.00 Å R-free 0.286 |
| 1OSG Complex between BAFF and a BR3 derived peptide presented in a beta-hairpin scaffold Deposited 2003-03-19 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
82–285(204 aa)
Fragment:TNF domain
Chain E
82–285(204 aa)
Fragment:TNF domain
Chain F
82–285(204 aa)
Fragment:TNF domain
|
Not recorded | MG MAGNESIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;292 K;20% PEG 3350, 1.0 M LiCl, 0.1M sodium cacodylate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 3.00 Å R-free 0.286 |
| 4V46 Crystal structure of the BAFF-BAFF-R complex Deposited 2003-03-23 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 120 PDB declaration: 120-meric |
Chain A0
138–285(148 aa)
Fragment:residues 138-285
Chain A1
138–285(148 aa)
Fragment:residues 138-285
Chain A2
138–285(148 aa)
Fragment:residues 138-285
Chain A3
138–285(148 aa)
Fragment:residues 138-285
Chain A4
138–285(148 aa)
Fragment:residues 138-285
Chain A5
138–285(148 aa)
Fragment:residues 138-285
Chain A6
138–285(148 aa)
Fragment:residues 138-285
Chain A7
138–285(148 aa)
Fragment:residues 138-285
Chain A8
138–285(148 aa)
Fragment:residues 138-285
Chain A9
138–285(148 aa)
Fragment:residues 138-285
Chain AA
138–285(148 aa)
Fragment:residues 138-285
Chain AB
138–285(148 aa)
Fragment:residues 138-285
Chain AC
138–285(148 aa)
Fragment:residues 138-285
Chain AD
138–285(148 aa)
Fragment:residues 138-285
Chain AE
138–285(148 aa)
Fragment:residues 138-285
Chain AF
138–285(148 aa)
Fragment:residues 138-285
Chain AG
138–285(148 aa)
Fragment:residues 138-285
Chain AH
138–285(148 aa)
Fragment:residues 138-285
Chain AI
138–285(148 aa)
Fragment:residues 138-285
Chain AJ
138–285(148 aa)
Fragment:residues 138-285
Chain AK
138–285(148 aa)
Fragment:residues 138-285
Chain AL
138–285(148 aa)
Fragment:residues 138-285
Chain AM
138–285(148 aa)
Fragment:residues 138-285
Chain AN
138–285(148 aa)
Fragment:residues 138-285
Chain AO
138–285(148 aa)
Fragment:residues 138-285
Chain AP
138–285(148 aa)
Fragment:residues 138-285
Chain AQ
138–285(148 aa)
Fragment:residues 138-285
Chain AR
138–285(148 aa)
Fragment:residues 138-285
Chain AS
138–285(148 aa)
Fragment:residues 138-285
Chain AT
138–285(148 aa)
Fragment:residues 138-285
Chain AU
138–285(148 aa)
Fragment:residues 138-285
Chain AV
138–285(148 aa)
Fragment:residues 138-285
Chain AW
138–285(148 aa)
Fragment:residues 138-285
Chain AX
138–285(148 aa)
Fragment:residues 138-285
Chain AY
138–285(148 aa)
Fragment:residues 138-285
Chain AZ
138–285(148 aa)
Fragment:residues 138-285
Chain Aa
138–285(148 aa)
Fragment:residues 138-285
Chain Ab
138–285(148 aa)
Fragment:residues 138-285
Chain Ac
138–285(148 aa)
Fragment:residues 138-285
Chain Ad
138–285(148 aa)
Fragment:residues 138-285
Chain Ae
138–285(148 aa)
Fragment:residues 138-285
Chain Af
138–285(148 aa)
Fragment:residues 138-285
Chain Ag
138–285(148 aa)
Fragment:residues 138-285
Chain Ah
138–285(148 aa)
Fragment:residues 138-285
Chain Ai
138–285(148 aa)
Fragment:residues 138-285
Chain Aj
138–285(148 aa)
Fragment:residues 138-285
Chain Ak
138–285(148 aa)
Fragment:residues 138-285
Chain Al
138–285(148 aa)
Fragment:residues 138-285
Chain Am
138–285(148 aa)
Fragment:residues 138-285
Chain An
138–285(148 aa)
Fragment:residues 138-285
Chain Ao
138–285(148 aa)
Fragment:residues 138-285
Chain Ap
138–285(148 aa)
Fragment:residues 138-285
Chain Aq
138–285(148 aa)
Fragment:residues 138-285
Chain Ar
138–285(148 aa)
Fragment:residues 138-285
Chain As
138–285(148 aa)
Fragment:residues 138-285
Chain At
138–285(148 aa)
Fragment:residues 138-285
Chain Au
138–285(148 aa)
Fragment:residues 138-285
Chain Av
138–285(148 aa)
Fragment:residues 138-285
Chain Aw
138–285(148 aa)
Fragment:residues 138-285
Chain Ax
138–285(148 aa)
Fragment:residues 138-285
|
Not recorded | MG MAGNESIUM ION × 40 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;sodium formate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 3.30 Å R-free 0.226 |
| 4ZCH Single-chain human APRIL-BAFF-BAFF Heterotrimer Deposited 2015-04-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
140–285(146 aa)
|
Not recorded | 144 TRIS-HYDROXYMETHYL-METHYL-AMMONIUM × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;RESERVOIR SOLUTION : 14% PEG6000 , 1M LiCL , TRIS-HCL pH 8.50
|
Resolution 2.43 Å R-free 0.234 |
| 4ZCH Single-chain human APRIL-BAFF-BAFF Heterotrimer Deposited 2015-04-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
140–285(146 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;RESERVOIR SOLUTION : 14% PEG6000 , 1M LiCL , TRIS-HCL pH 8.50
|
Resolution 2.43 Å R-free 0.234 |
| 5Y9J BAFF in complex with belimumab Deposited 2017-08-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
134–285(152 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8.5;293 K;0.1 M Tris(hydroxymethyl)aminomethane pH 8.5, 20% (w/v)polyethylene glycol 1,000
|
Resolution 2.05 Å R-free 0.217 |
| 6FXN Crystal structure of human BAFF in complex with Fab fragment of anti-BAFF antibody belimumab Deposited 2018-03-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 9 PDB declaration: nonameric |
Chain A
134–285(152 aa)
Chain B
134–285(152 aa)
Chain C
134–285(152 aa)
|
Mutation:H218A Mutation:H218A Mutation:H218A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;9% (w/v) PEG4000, 0.1 M MgCl2, 0.1 M HEPES pH 7.5
|
Resolution 2.90 Å R-free 0.231 |
| 6FXN Crystal structure of human BAFF in complex with Fab fragment of anti-BAFF antibody belimumab Deposited 2018-03-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 9 PDB declaration: nonameric |
Chain J
134–285(152 aa)
Chain K
134–285(152 aa)
Chain L
134–285(152 aa)
|
Mutation:H218A Mutation:H218A Mutation:H218A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;9% (w/v) PEG4000, 0.1 M MgCl2, 0.1 M HEPES pH 7.5
|
Resolution 2.90 Å R-free 0.231 |
| 8ZUJ Pentagonal cluster of BAFF-BAFFR ectodomain complex Deposited 2024-06-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric |
Chain D
134–285(152 aa)
Chain E
134–285(152 aa)
Chain F
134–285(152 aa)
Chain J
134–285(152 aa)
Chain K
134–285(152 aa)
Chain L
134–285(152 aa)
Chain P
134–285(152 aa)
Chain Q
134–285(152 aa)
Chain R
134–285(152 aa)
Chain V
134–285(152 aa)
Chain W
134–285(152 aa)
Chain X
134–285(152 aa)
Chain b
134–285(152 aa)
Chain c
134–285(152 aa)
Chain d
134–285(152 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.58 Å |
11 other PDB entries and 16 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | TN13B_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 5–208; UniProt 82–285 Author chain B; PDBConstruct 5–208; UniProt 82–285 Author chain C; PDBConstruct 5–208; UniProt 82–285 Author chain D; PDBConstruct 5–208; UniProt 82–285 Author chain E; PDBConstruct 5–208; UniProt 82–285 Author chain F; PDBConstruct 5–208; UniProt 82–285 |